Literature DB >> 11673525

The initiation of B cell clonal expansion occurs independently of pre-B cell receptor formation.

G H Kline1, T A Hayden, P Riegert.   

Abstract

Current models of B cell development posit that clonal expansion occurs as a direct result of Ig H chain expression. To test this hypothesis, we isolated a population of early B cells in which H chain recombination is initiated and assessed V(H)DJ(H) rearrangements in both cycling and noncycling cells. We found that actively dividing cells within this population are enriched for H chain rearrangements that are productive when compared with their counterparts in G(0)/G(1), apparently supporting a role for H chain expression in initiating early B cell division; entrance into the cell cycle was accompanied by V(H) gene-dependent H chain selection. However, we also identified a phenotypically identical population of actively cycling early B cells in the absence of H chain expression in recombination activating gene knockout mice. In addition, actively cycling early B cells could be detected in pre-B cell receptor (pBCR)-negative lambda5 knockout mice, but we found no evidence for V(H)-dependent H chain selection in this population. Given these results, we suggest that the initiation of clonal expansion, at this early stage in B cell development, occurs independently of H chain expression. Although the cycling cell pool is enriched for pBCR-positive cells in mice expressing surrogate L chain, pBCR formation is not required for the initiation of cell division.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673525     DOI: 10.4049/jimmunol.167.9.5136

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  1 in total

1.  The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas.

Authors:  Yosef Refaeli; Ryan M Young; Brian C Turner; Jennifer Duda; Kenneth A Field; J Michael Bishop
Journal:  PLoS Biol       Date:  2008-06-24       Impact factor: 8.029

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.